Multiple splicing variants of the estrogen receptor are present in individual human breast tumors

Journal of Steroid Biochemistry and Molecular Biology

Volumn 59, Issue 3-4, 1996, Pages 251-260

  Zhang, Qiu Xia ^a   Hilsenbeck, Sue G ^b   Fuqua, Suzanne A W ^b   Borg, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DELETION MUTANT; EXON; FEMALE; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECURRENCE; RNA, MESSENGER; RNA, NEOPLASM; TAMOXIFEN;

EID: 0030292856     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00120-3     Document Type: Article

References (28)

1. 1. Dickson R. B. and Lippman M. E.: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinomas. Endocr. Rev. 8 (1987) 29-43.
2. 2. Clark G. M. and McGuire W. L.: Steroid receptors and other prognostic factors in primary breast cancer. Semin. Oncol. 15 (1988) 20-25.
3. 3. Sluyser M. and Mester L.: Oncogenes homologous to steroid receptors?. Nature 315 (1985) 546.
4. 4. Fuqua S. A. W., Chamness G. C. and McGuire W. L.: Estrogen receptor mutations in breast cancer. J. Cell. Biochem. 51 (1993) 135-139.
5. 5. Miksicek R. J.: Steroid receptor variants and their potential role in cancer. Semin. Cancer Biol. 5 (1994) 369-379.
6. 6. Kumar V., Green S., Stack G., Berry M., Jin J. R. and Chambon P.: Functional domains of the human estrogen receptor. Cell 51 (1987) 941-951.
7. 7. McDonnell D. P., Clemm D. L. and Imhof M. O.: Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Semin. Cancer Biol. 5 (1994) 327-336.
8. 8. Fuqua S. A. W., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W. and McGuire W. L.: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51 (1991) 105-109.
9. 9. Fuqua S. A. W., Fitzgerald S. D., Allred C., Elledge R. M., Nawaz Z., McDonnell D. P., Nawaz Z., O'Malley B. W., Greene G. L. and McGuire W. L.: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 52 (1992) 483-486.
10. 10. Dotzlaw H. and Murphy L. C.: Cloning and sequencing of a variant sized estrogen receptor (ER) mRNA detected in some breast cancer biopsies. Breast Cancer Res. Treat. 16 (1990) 147.
11. 11. Wang Y. and Miksicek R. J.: Identification of a dominant negative form of the human estrogen receptor. Molec Endocr. 5 (1990) 1707-1715.
12. 12. Zhang Q.-X., Borg Å. and Fuqua S. A. W.: An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in breast cancer. Cancer Res. 53 (1993) 5882-5884.
13. 13. Koehorst S. G. A., Jacobs H. M., Thijssen J. H. H. and Blankenstein M. A.: Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. J. Steroid Biochem. Molec. Biol. 45 (1993) 227-233.
14. 14. Pfeffer U., Fecarotta E., Castsgnetta L. and Vidali G.: Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res. 53 (1993) 741-743.
15. 15. Miksicek R. J., Lei Y. and Wang Y.: Exon skipping gives rise to alternatively spiced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Treat. 26 (1993) 163-174.
16. 16. Chomczynski P. and Sacchi N.: Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162 (1987) 156-159.
17. 17. Greene G. L., Gilna P., Waterfield M., Baker A., Hort Y. and Shine L.: Sequence and expression of human estrogen receptor complementary DNA. Science 231 (1986) 1150-1154.
18. 18. Sanger F., Nicklen S. and Coulson A. R.: DNA sequencing with chain-terminating inhibitors. Proc. Natn. Acad. Sci. U.S.A. 74 (1977) 5463-5467.
19. 19. Koehorst S. G. A., Cox J. J., Donker G. H., Dasilva S. L., Burbach J. P. H., Thijssen J. H. H. and Blankenstein M. A.: Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Molec. Cell. Endocr. 101 (1994) 237-245.
20. 20. Daffada A. A. I., Johnston S. R. D., Smith I. E., Detre S., King N. and Dowsett M.: Exon 5 deletion variant receptor messenger RNA expression in relation to tamoxifen resistance and progestrone receptor/pS2 status in human breast cancer. Cancer Res. 55 (1995) 288-293.
21. 21. Osborne C. K. and Fuqua S. A. W.: Mechanisms of tamoxifen resistance. Breast Cancer Res. Treat. 32 (1994) 49-55.
22. 22. Borg Å., Baldetorp B., Fernö M., Olsson H., Rydén S., Sigurdsson H. and Killander D.: ERBB2 amplification in tamoxifen resistant steroid receptor positive breast cancer. Cancer Lett. 81 (1994) 137-144.
23. R-1 compared to the parental MCF-7 cell line. Molec. Cell. Endocr. 109 (1995) 197-207.
24. 24. Fuqua S. A. W., Wolf D. M., Zhang Q.-X., Castles C. G., O'Connell P., Allred D. C. and Wiltschke C.: The role of the estrogen receptor in tumor progression. J. Steroid Biochem. Molec. Biol. (1996) in press.
25. 25. Sicinski P., Donaher J. L., Parker S. B., Li T. S., Gardner H., Haslam S. Z., Bronson R. T., Elledge S. J. and Weinberg R. A.: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82 (1995) 621-630.
26. 26. Borg Å., Sigurdsson H., Clark G. M., Fernö M., Fuqua S. A. W., Olsson H., Killander D. and McGuire W. L.: Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer 63 (1991) 138-142.
27. 27. Pfeffer U., Fecarotta E. and Vidali G.: Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res. 55 (1995) 2158-2165.
28. 28. Keaveny M., Klug J., Dawson M. T., Nestor P. V., Neilan J. G., Forde R. C. and Gannon F.: Evidence for a previously unrecognized upstream exon in the human oestrogen receptor gene. J. Molec. Endocr. 6 (1991) 111-115.